Further, we ultimately identified and verified five genes (CAPS1, CASP5, GSDMD, AIM2, and NLRP3) as the hub pyroptosis genes for IBD patients, all of which were upregulated during the inflammatory status and could serve as potential biomarkers for diagnosing the disease. This evidence concerns the gene NLRP3 and inflammatory bowel disease.